- US-listed companies
- IONIS PHARMACEUTICALS INC
- Income statement
IONIS PHARMACEUTICALS INCIONS
Market cap
$12.8B
P/E ratio
| 2010/12 | 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | 108 | 99 | 102 | 147 | 214 | 284 | 347 | 508 | 600 | 1,123 | 729 | 810 | 587 | 788 | 705 |
| Revenue growth (%) | - | ||||||||||||||
| Cost of revenue | - | - | - | - | - | - | - | - | 2 | 4 | 12 | 11 | 14 | 9 | 11 |
| Research & development | 145 | 157 | 158 | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, general & administrative | - | - | - | - | - | - | - | 108 | 245 | 287 | 354 | 186 | 150 | 233 | 267 |
| Operating margin (%) | |||||||||||||||
| Operating income | -48 | -71 | -69 | -52 | -48 | -76 | -46 | 25 | -61 | 366 | -172 | -30 | -410 | -354 | -475 |
| Operating expenses | 157 | 170 | 171 | 199 | 262 | 359 | 393 | 483 | 661 | 757 | 901 | 841 | 998 | 1,141 | 1,180 |
| Income before tax | - | -85 | -75 | -67 | -54 | -88 | -84 | -23 | -76 | 347 | -170 | -29 | -258 | -334 | -460 |
| Pretax margin (%) | - | -85.6 | -73.1 | -45.2 | -25.4 | -31 | -24.1 | -4.6 | -12.7 | 30.9 | -23.3 | -3.6 | -43.9 | -42.4 | -65.2 |
| Provision for income taxes | 0 | 0 | - | - | -15 | 0 | 3 | -6 | -291 | 44 | 317 | -1 | 12 | 32 | -6 |
| Effective tax rate (%) | - | - | - | ||||||||||||
| Net income | -61 | -85 | -65 | -61 | -39 | -88 | -87 | -6 | 274 | 303 | -451 | -29 | -270 | -366 | -454 |
| Net income margin (%) | |||||||||||||||
| Earnings per share | -0.62 | -0.85 | - | - | - | - | - | 0.08 | 2.09 | 2.12 | -3.23 | -0.2 | -1.9 | -2.56 | -3.04 |
| Diluted EPS | -0.62 | -0.85 | - | - | - | - | - | 0.08 | 2.07 | 2.08 | -3.23 | -0.2 | -1.9 | -2.56 | -3.04 |